Nóbrega, Clévio
Mendonça, Liliana
Marcelo, Adriana
Lamazière, Antonin
Tomé, Sandra
Despres, Gaetan
Matos, Carlos A.
Mechmet, Fatich
Langui, Dominique
den Dunnen, Wilfred
de Almeida, Luis Pereira
Cartier, Nathalie
Alves, Sandro http://orcid.org/0000-0002-1396-7523
Article History
Received: 2 October 2018
Revised: 4 April 2019
Accepted: 20 April 2019
First Online: 14 June 2019
Compliance with ethical standards
:
: The authors declare financial interest. CN, LM, NC, LPA and SA are inventors of patent applications claiming the use of AAV-CYP46A1 therapy in spinocerebellar ataxias.